Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Meningococcal Vaccination

Meningococcal vaccines routinely used in the United States protect against most types of meningococcal disease, but they do not prevent all cases. There are two kinds of vaccines against Neisseria meningitidis bacteria available in the United States: meningococcal polysaccharide vaccine (Menomune®) and meningococcal conjugate vaccine (Menactra®, Menveo® and MenHibrix®).

For more information on meningococcal vaccines and who should receive them, visit the Meningococcal Vaccine site or Recommendations of the Advisory Committee on Immunization Practices.

What You Need to Know about the Meningococcal Vaccine

Meningococcal Vaccine Resources for Health Care Professionals

Vaccination Coverage

The National Immunization Survey (NIS) is a large, on-going survey of immunization coverage among US pre-school children (19-35 months of age). In conjunction with the NIS, CDC also conducts the NIS-Teen (13 to 17 years of age) and the NIS-Adult.

Top of Page

Related Pages

Top